Primary Open Angle Glaucoma Clinical Trial
Official title:
A Cross Sectional Study of Correlation Between Retinal Nerve Fibre Thickness Measured by Optical Coherence Tomography and Humphrey Visual Fields in Early and Moderate Open Angle Glaucoma
Glaucoma is an optic neuropathy characterised by progressive degeneration of retinal
ganglion cells and axons that leads to nerve fibre loss, optic disc cupping, and consecutive
glaucomatous visual field defects. It is considered to be one of the major causes of
blindness worldwide.
It is a well accepted fact least 25 - 40% of retinal ganglion cells need to be lost before
statistically detectable visual field defects appear on automated visual field testing,
which is also consistent with post-mortem histologic findings in glaucomatous eyes. Since
the damage associated with glaucoma is irreversible, and retinal nerve fibre layer loss is
considered as an early sign of glaucomatous damage, its early detection and prevention is
warranted. Retinal nerve fibre layer studies can be undertaken through non - invasive,
reproducible technologies such as optical coherence tomography, scanning laser polarimetry
etc.
The purpose of the study is to evaluate the relationship between visual fields and retinal
nerve fibre layer thickness as measured by Cirrus spectral domain optical coherence
tomography with visual fields by Humphrey Field Analyser (HFA) in early and moderate primary
open - angle glaucoma.
It is often said that the structural damage due to glaucoma precedes functional loss, it is
not always clear in its interpretation. To define, which test shows up the earliest sign of
glaucomatous damage would be difficult to predict, since the outcome can be influenced by
many factors, such as the sensitivity of the test, inter - individual difference or the
stage of the disease process itself. Studies on post-mortem retinal ganglion cells counts
and SAP field loss in humans and monkeys lead to an observation that, on an average about
25% retinal ganglion cells loss leads to development of an afferent pupillary defect, 35%
loss for visual field defects and 40% loss leads to worsening of visual acuity. It would be
safe to state that a) the most important clinical challenge is early detection of
glaucomatous damage and progression over a period of time; b) Both structural and functional
tests are important in assessing early damage and progression; c) significant damage to the
retinal ganglion cells can occur before standard tests detect a functional loss in vision.
These have paved the way to the development of many studies on the structure - function
correlation and stating linear models for the same. However these studies present a dilemma;
is the structure - function relation on glaucoma, a statistical statement (a structural
measure will reach significance before a functional test) or relational statement
(statistical correlation between the structural and functional tests).
We propose to evaluate the structure - function correlation in early and moderate open -
angle glaucoma by assessing the retinal nerve fibre layer thickness by Spectral Domain
Optical Coherence Tomography and areas of decreased visual field sensitivity given by
Humphrey 24 - 2 Swedish Interactive Threshold Algorithm Standard protocol of automated
perimetry and determine any representational or statistical significance, if any between the
two tests.
;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05564091 -
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
|
N/A | |
Recruiting |
NCT02792803 -
A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
|
Phase 4 | |
Terminated |
NCT02801617 -
Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT01384149 -
EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA
|
Phase 1 | |
Completed |
NCT00300079 -
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
|
Phase 4 | |
Enrolling by invitation |
NCT00221923 -
African Descent and Glaucoma Evaluation Study
|
||
Recruiting |
NCT05605743 -
Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure
|
N/A | |
Completed |
NCT04828057 -
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
|
||
Completed |
NCT01442896 -
STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk
|
||
Enrolling by invitation |
NCT05557721 -
Uddevalla Skövde Transscleral Micropulse Study
|
||
Recruiting |
NCT04595227 -
Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device
|
||
Terminated |
NCT04141865 -
Effect of Xen Implantation on the Aqueous Humor Proteome
|
||
Completed |
NCT01943721 -
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
|
Phase 1 | |
Completed |
NCT01979913 -
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
|
Phase 4 | |
Completed |
NCT02023242 -
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
|
N/A | |
Not yet recruiting |
NCT01711177 -
Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
|
N/A | |
Completed |
NCT01769521 -
Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG
|
N/A | |
Recruiting |
NCT00773123 -
Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.
|
N/A | |
Recruiting |
NCT00773877 -
Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients
|
N/A | |
Completed |
NCT02544646 -
Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG
|
N/A |